Rhythm Biosciences Ltd has released a press release.
Final Antibody Selection Complete
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Earlier from Rhythm Biosciences
- Rhythm completes cloning of key reagent ahead of schedule
- Rhythm Granted Biomarker Patent in Europe
- RHYs Four Antibodies Pass all Three Key Screening Tests
- Reagent Development Update
- Appendix 4D - Half Yearly Report
Later from Rhythm Biosciences
- AGM Presentation
- Appointment of CEO - Senior Management Changes
- Rhythm Completes Reagent Development Program
- Corporate Presentation
- RHY Signs first ColoSTAT site for Clinical Trial - Study 7
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences